Literature DB >> 29739713

Volumetric modulated arc therapy of head-and-neck cancer on a fast-rotating O-ring linac: Plan quality and delivery time comparison with a C-arm linac.

Steven Michiels1, Kenneth Poels2, Wouter Crijns2, Laurence Delombaerde3, Robin De Roover3, Bianca Vanstraelen2, Karin Haustermans4, Sandra Nuyts4, Tom Depuydt5.   

Abstract

BACKGROUND AND
PURPOSE: Linac improvements in gantry speed, leaf speed and dose rate may increase the time-efficiency of volumetric modulated arc therapy (VMAT) delivery. The plan quality achievable with faster VMAT however remains to be investigated. In this study, a fast-rotating O-ring linac with fast-moving leaves is compared with a C-arm linac in terms of plan quality and delivery time for VMAT of head-and-neck cancer (HNC).
MATERIAL AND METHODS: For 30 patients with HNC, treatment planning was performed using dual-arc (HA2) and triple-arc (HA3) VMAT on a Halcyon fast-rotating O-ring linac and using dual-arc VMAT on a TrueBeam C-arm linac (TB2). Target coverage metrics and complication probabilities were compared. Plan delivery was verified using 3%/3 mm gamma-index analysis of helical diode array measurements. Volumetric image acquisition and plan delivery times were compared.
RESULTS: All studied VMAT-techniques fulfilled the target coverage objectives. D2% to the boost volume was higher for HA2 (median 103.7%, 1st-3rd quartile [103.5%;104.0%]) and HA3 (103.2% [103.0%;103.7%)] than for TB2 (102.6% [102.3%;103.0%)], resulting in an increased boost target dose heterogeneity for HA2 and HA3. Complication probabilities were comparable between HA2 and TB2, while HA3 showed a xerostomia probability reduction (0.8% [0.2%;1.8%]) and dysphagia probability reduction (1.0% [0.2%;1.8%]) compared with TB2. Gamma-index agreement scores were never below 93.0% for HA2, HA3 and TB2. Volumetric imaging and plan delivery time was shorter for HA2 (1 m 24 s ± 1 s) and HA3 (1 m 54 s ± 1 s) than for TB2 (2 m 47 s ± 1 s).
CONCLUSION: For VMAT of HNC, the fast-rotating O-ring linac at least maintains the plan quality of two arcs on a C-arm linac while reducing the image acquisition and plan delivery time.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  FFF; Fast-rotating O-ring linac; Head-and-neck cancer; Plan quality; Treatment time; VMAT

Mesh:

Year:  2018        PMID: 29739713     DOI: 10.1016/j.radonc.2018.04.021

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  22 in total

1.  Characterization of a prototype rapid kilovoltage x-ray image guidance system designed for a ring shape radiation therapy unit.

Authors:  Bin Cai; Eric Laugeman; Thomas R Mazur; Justin C Park; Lauren E Henke; Hyun Kim; Geoffrey D Hugo; Sasa Mutic; Hua Li
Journal:  Med Phys       Date:  2019-02-13       Impact factor: 4.071

2.  Effect of the simulated half leaf width of a multileaf collimator on volumetric modulated arc therapy plan quality in hippocampal avoidance whole-brain radiotherapy.

Authors:  Ming-Hsien Li; Li-Jhen Chen; Chih-Chieh Chang; Jo-Ting Tsai; Jang-Chun Lin
Journal:  J Appl Clin Med Phys       Date:  2022-03-03       Impact factor: 2.243

3.  Comprehensive validation of halcyon 2.0 plans and the implementation of patient specific QA with multiple detector platforms.

Authors:  Eric Laugeman; Ana Heermann; Jessica Hilliard; Michael Watts; Marshia Roberson; Robert Morris; Sreekrishna Goddu; Abhishek Sethi; Imran Zoberi; Hyun Kim; Sasa Mutic; Geoffrey Hugo; Bin Cai
Journal:  J Appl Clin Med Phys       Date:  2020-05-05       Impact factor: 2.102

4.  Impact of Multi-leaf Collimator Parameters on Head and Neck Plan Quality and Delivery: A Comparison between Halcyon™ and Truebeam® Treatment Delivery Systems.

Authors:  Taoran Li; Ryan Scheuermann; Alexander Lin; Boon-Keng Kevin Teo; Wei Zou; Samuel Swisher-McClure; Michelle Alonso-Basanta; John N Lukens; Alireza Fotouhi Ghiam; Chris Kennedy; Michele M Kim; Dimitris Mihailidis; James M Metz; Lei Dong
Journal:  Cureus       Date:  2018-11-28

5.  Field-in-field breast planning for a jawless, double-stack MLC LINAC using flattening-filter-free beams.

Authors:  Robert Morris; Eric Laugeman; Jessica Hilliard; Imran Zoberi; Ana Heerman; Geoffrey Hugo; Sasa Mutic; Bin Cai
Journal:  J Appl Clin Med Phys       Date:  2019-10-16       Impact factor: 2.102

6.  Dosimetric Evaluation of Simplified Knowledge-Based Plan with an Extensive Stepping Validation Approach in Volumetric-Modulated Arc Therapy-Stereotactic Body Radiotherapy for Lung Cancer.

Authors:  Yutaro Wada; Hajime Monzen; Mikoto Tamura; Masakazu Otsuka; Masahiro Inada; Kazuki Ishikawa; Hiroshi Doi; Kiyoshi Nakamatsu; Yasumasa Nishimura
Journal:  J Med Phys       Date:  2021-05-05

7.  Critical Appraisal of the Treatment Planning Performance of Volumetric Modulated Arc Therapy by Means of a Dual Layer Stacked Multileaf Collimator for Head and Neck, Breast, and Prostate.

Authors:  Luca Cozzi; Antonella Fogliata; Stephen Thompson; Ciro Franzese; Davide Franceschini; Fiorenza de Rose; Stefano Tomatis; Marta Scorsetti
Journal:  Technol Cancer Res Treat       Date:  2018-01-01

8.  Initial Clinical Experience Treating Patients with Breast Cancer on a 6-MV Flattening-Filter-Free O-Ring Linear Accelerator.

Authors:  Andrew R Barsky; Fionnbarr O'Grady; Christopher Kennedy; Neil K Taunk; Lei Dong; James M Metz; Taoran Li; Gary M Freedman
Journal:  Adv Radiat Oncol       Date:  2019-06-08

9.  Reliability of ITV approach to varying treatment fraction time: a retrospective analysis based on 2D cine MR images.

Authors:  Davide Cusumano; Jennifer Dhont; Luca Boldrini; Giuditta Chiloiro; Angela Romano; Claudio Votta; Silvia Longo; Lorenzo Placidi; Luigi Azario; Marco De Spirito; Dirk Verellen; Vincenzo Valentini
Journal:  Radiat Oncol       Date:  2020-06-12       Impact factor: 3.481

10.  Early clinical experience with varian halcyon V2 linear accelerator: Dual-isocenter IMRT planning and delivery with portal dosimetry for gynecological cancer treatments.

Authors:  Hayeon Kim; M Saiful Huq; Ron Lalonde; Christopher J Houser; Sushil Beriwal; Dwight E Heron
Journal:  J Appl Clin Med Phys       Date:  2019-10-29       Impact factor: 2.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.